What Cara Meredith’s book gets right about church camp - Baptist News Global
7 hours ago • Google News
Cara Therapeutic (CARA)
US$ 5-2.34%
Price Chart
Key Statistics
Market Cap
$ 8.11M
P/E Ratio
0.00
Revenue (TTM)
$ 7.14M
Volume
8.59K
52W High
$ 25.53
52W Low
$ 8.13
Dividend Yield
0.00%
Beta
0.41
Technicals
50-Day MA
15.2115
200-Day MA
12.7954
52 Week High
25.53
52 Week Low
8.1252
About CARA
Cara Therapeutics, Inc. operates as a biopharmaceutical company that focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States.
Employees
10
Headquarters
Stamford, CT
CEO
Mr. Christopher A. Posner
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg